<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00032916</url>
  </required_header>
  <id_info>
    <org_study_id>NIDA-CPU-2359-02-1</org_study_id>
    <nct_id>NCT00032916</nct_id>
    <nct_alias>NCT00031330</nct_alias>
  </id_info>
  <brief_title>Drug Interaction Study With NS2359 and Cocaine in Cocaine Experienced Volunteers - 1</brief_title>
  <official_title>Drug Interaction Study With NS2359 and Cocaine in Cocaine Experienced Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institute on Drug Abuse (NIDA)</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to conduct a drug interaction study with NS2359 and cocaine in
      cocaine experienced volunteers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single-center, double-blind, placebo-controlled, randomized, single dose, fixed
      order, dose escalating inpatient design that will study oral NS2359 in cocaine experienced
      volunteers.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>June 2001</start_date>
  <completion_date>December 2002</completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pharmacokinetic parameter comparison</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>plasma concentration</measure>
  </primary_outcome>
  <enrollment>24</enrollment>
  <condition>Cocaine-Related Disorders</condition>
  <condition>Drug Administration Schedule</condition>
  <condition>Infusions, Intravenous</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NS2359</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Male or Female, 18-45 yrs of age; females of child-bearing potential using appropriate
        method of birth control; be able to understand the procedure and agrees to participate via
        informed consent; must be cocaine dependent according to DSM-4 criteria; must be capable of
        providing written consent; must be able to comply with protocol requirement, CPU rules and
        regulations; must not be currently seeking treatment for cocaine abuse.

        Exclusion Criteria:

        Incapable of understanding the informed consent process; Additional criteria available
        during screening at the site.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Louis Cantilena, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Uniformed Services University of Health Science</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Uniformed Services University of Health Science</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20814 4799</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2004</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 5, 2002</study_first_submitted>
  <study_first_submitted_qc>April 5, 2002</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 8, 2002</study_first_posted>
  <last_update_submitted>January 10, 2017</last_update_submitted>
  <last_update_submitted_qc>January 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 11, 2017</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cocaine-Related Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

